Literature DB >> 9176389

Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination.

R M de Waal1, M C van Altena, H Erhard, U H Weidle, P T Nooijen, D J Ruiter.   

Abstract

Cutaneous melanoma has an initial preference for lymphatic spread. Remarkably, melanoma progression toward this metastasizing phenotype is accompanied by intense blood vessel angiogenesis (hemangiogenesis), but lymphangiogenesis, the formation of new lymph vessels in the tumor, has never been reported. To investigate how primary melanoma cells interact with the existing lymphatic microvasculature, and whether lymphangiogenesis occurs, an immunostaining was developed that differentially decorates blood and lymph vessels in frozen tissue sections. The density and distribution of both these vessel types in and around thin (< or = 1.5 mm) and thick (> or = 1.5 mm) primary melanoma lesions and in normal and uninvolved skin were determined. Although especially in thick melanoma lesions a significant increase in blood vessel density was observed, lymphatic density remained unaltered, showing that lymphangiogenesis did not occur. Morphological analysis indicated, however, that melanoma progression is accompanied by a sequence of events that involves hemangiogenesis supporting tumor expansion, especially in the vertical growth phase. Often, stromal sepia are formed around the blood capillaries in the tumor neovasculature protecting them from invasion. Lymph vessels inside the tumor were infrequently observed. However, subepidermal lymph vessels often seemed to be entrapped and penetrated by the expanding tumor mass. In this way, hemangiogenesis, as the driving force behind tumor expansion, might indirectly increase the chance of lymphatic invasion in the absence of lymphangiogenesis. This model explains the paradox that, although melanoma metastasis seems to require angiogenesis, a consistent relation of prognosis with blood capillary density in primary cutaneous melanoma is lacking.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176389      PMCID: PMC1858323     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  What is the evidence that tumors are angiogenesis dependent?

Authors:  J Folkman
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

Review 2.  Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

Authors:  L A Liotta; P S Steeg; W G Stetler-Stevenson
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

3.  Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4 mm) cutaneous melanoma. A quantitative assay.

Authors:  F Rongioletti; C Miracco; C Gambini; A Pastorino; P Tosi; A Rebora
Journal:  Am J Dermatopathol       Date:  1996-10       Impact factor: 1.533

4.  Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy.

Authors:  I W McLean; P K Nakane
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

5.  Lymphatics in primary cutaneous melanoma.

Authors:  M E Fallowfield; M G Cook
Journal:  Am J Surg Pathol       Date:  1990-04       Impact factor: 6.394

6.  PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily.

Authors:  P J Newman; M C Berndt; J Gorski; G C White; S Lyman; C Paddock; W A Muller
Journal:  Science       Date:  1990-03-09       Impact factor: 47.728

7.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

Authors:  N Weidner; J P Semple; W R Welch; J Folkman
Journal:  N Engl J Med       Date:  1991-01-03       Impact factor: 91.245

Review 8.  Monoclonal antibody-defined human endothelial antigens as vascular markers.

Authors:  D J Ruiter; R O Schlingemann; F J Rietveld; R M de Waal
Journal:  J Invest Dermatol       Date:  1989-08       Impact factor: 8.551

9.  The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study.

Authors:  A Srivastava; P Laidler; R P Davies; K Horgan; L E Hughes
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

10.  A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions.

Authors:  W A Muller; C M Ratti; S L McDonnell; Z A Cohn
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Current concepts of tumor-induced angiogenesis.

Authors:  S Paku
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

2.  VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.

Authors:  R Valtola; P Salven; P Heikkilä; J Taipale; H Joensuu; M Rehn; T Pihlajaniemi; H Weich; R deWaal; K Alitalo
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

3.  Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.

Authors:  D Massi; S Puig; A Franchi; J Malvehy; S Vidal-Sicart; M González-Cao; G Baroni; S Ketabchi; J Palou; M Santucci
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

4.  Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.

Authors:  A Lymboussaki; T A Partanen; B Olofsson; J Thomas-Crusells; C D Fletcher; R M de Waal; A Kaipainen; K Alitalo
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

Review 5.  Lymphatics at the crossroads of angiogenesis and lymphangiogenesis.

Authors:  Claudio Scavelli; Elisabetta Weber; Margherita Aglianò; Teresa Cirulli; Beatrice Nico; Angelo Vacca; Domenico Ribatti
Journal:  J Anat       Date:  2004-06       Impact factor: 2.610

6.  Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.

Authors:  Soheil S Dadras; Thomas Paul; Jennifer Bertoncini; Lawrence F Brown; Alona Muzikansky; David G Jackson; Ulf Ellwanger; Claus Garbe; Martin C Mihm; Michael Detmar
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

Review 7.  Lymphatic vessels as targets of tumor therapy?

Authors:  T Karpanen; K Alitalo
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

Review 8.  Dissecting the Lymphatic System to Predict Melanoma Metastasis.

Authors:  Rishi Suresh; Arturas Ziemys; Ashley M Holder
Journal:  Front Oncol       Date:  2020-11-27       Impact factor: 6.244

9.  Lymphatic density and metastatic spread in human malignant melanoma.

Authors:  J D Shields; M Borsetti; H Rigby; S J Harper; P S Mortimer; J R Levick; A Orlando; D O Bates
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.